MARKET WIRE NEWS
  1. Home
  2. Stock
  3. APS:CC
  4. News
APS:CC
Quote
Short
News
Articles
Message Board

Aptose Biosciences Inc. (TSXC : APS:CC ) News

Aptose Biosciences Inc. (TSXC: APS:CC) News Releases

APS:CC News Releases
APS:CC : TSXC
Canadian Earnings Reports
Expected earnings - Aptose Biosciences Inc.
APS:CC : TSXC
GlobeNewswire
Aptose Reports Second Quarter 2025 Results
APS:CC : TSXC
GlobeNewswire
Aptose Enrollment is Open for 160 mg Dosing Cohort of Tuspetinib in Phase 1/2 TUSCANY Trial of Frontline Triple Drug Therapy
APS:CC : TSXC
GlobeNewswire
Aptose Selects Ernst & Young Global Limited as its New Independent Auditor and Calls Reconvened Meeting of its Shareholders
APS:CC : TSXC
GlobeNewswire
Aptose Receives Second Advance under the Loan Agreement with Hanmi Pharmaceutical to Continue Development of Tuspetinib in Triplet Therapy for AML
APS:CC : TSXC
GlobeNewswire
Aptose Upgraded to Trade on OTCQB Market
APS:CC : TSXC
GlobeNewswire
Aptose Announces Deferral of Interest Payment
APS:CC : TSXC
GlobeNewswire
Aptose and Hanmi Enter New Loan Agreement to Advance Development of Tuspetinib in Triplet Therapy for AML
APS:CC : TSXC
GlobeNewswire
Aptose Provides Corporate Updates
APS:CC : TSXC
GlobeNewswire
Aptose Presents Safety, Response, and MRD Clinical Data from TUSCANY Phase 1/2 Clinical Trial of Tuspetinib Triplet Therapy in Newly Diagnosed AML at the 2025 EHA Congress
Back to Start

Subscribe to Our Newsletter

Get Instant Newsletter Alerts to your Mobile Device and Email as soon as the News or Alerts hit the wire.

Download The Market Wire News App

Get instant news alerts to your mobile device as soon as the news hits the wire. Simply add a stock symbol to your portfolio and our service will alert you anytime there is news.

Market Wire News iPhone App Market Wire News Android App

Link Market Wire News to Your X Account

Link your X account with Market Wire News to automatically tweet trending stocks news and your portfolio stocks news.